Correction to: Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors
Titel:
Correction to: Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors
Auteur:
Patnaik, Amita Gadgeel, Shirish Papadopoulos, Kyriakos P. Rasco, Drew W. Haas, Naomi B. Der-Torossian, Hirak Faltaos, Demiana Potvin, Diane Tassell, Vanessa Tawashi, Manal Chao, Richard O’Dwyer, Peter J.